Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Diseases (3)
- Medical Specialties (2)
- Respiratory Tract Diseases (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Applied Mathematics (1)
-
- Bacterial Infections and Mycoses (1)
- Diagnosis (1)
- Epidemiology (1)
- Genetics and Genomics (1)
- Infectious Disease (1)
- Laboratory Medicine (1)
- Life Sciences (1)
- Medical Microbiology (1)
- Medical Molecular Biology (1)
- Medical Sciences (1)
- Microbiology (1)
- Molecular Genetics (1)
- Numerical Analysis and Computation (1)
- Pathogenic Microbiology (1)
- Pathology (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Physical Sciences and Mathematics (1)
- Public Health (1)
- Surgery (1)
- Institution
- Keyword
-
- Allergic fungal rhinosinusitis (1)
- Aspergillus fumigatus (1)
- Asthma (1)
- Carbon source utilization (1)
- Cell wall integrity (1)
-
- Clinical (1)
- CotA (1)
- Dgs (1)
- Diagnostic (1)
- Diagnostic genetic sciences (1)
- Diasorin (1)
- Dupilumab (1)
- Filamentous growth (1)
- Fungal (1)
- Fungal morphogenesis (1)
- Fungi (1)
- Infectious disease (1)
- Molecular (1)
- PCR (1)
- PJP (1)
- Pneumocystis jirovecii (1)
- Pneumonia (1)
- Quality of life (1)
- Regulation of Ace2 and Morphogenesis (RAM) pathway (1)
- Stress response (1)
- Surgery (1)
- Systemic corticosteroids (1)
- Type 2 inflammation (1)
- Validation (1)
- Publication
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Fungi
Characterization Of Regulation Of Ace2 And Morphogenesis (Ram) Pathway Components In Aspergillus Fumigatus, Devi Naga Jyothi Bale
Characterization Of Regulation Of Ace2 And Morphogenesis (Ram) Pathway Components In Aspergillus Fumigatus, Devi Naga Jyothi Bale
Theses and Dissertations (ETD)
Aspergillus fumigatus CotA is a conserved protein kinase and predicted orthologue of Cbk1, a terminal kinase of the Regulation of Ace2 and Morphogenesis (RAM) network. In our previous study, disruption of CotA resulted in carbon source dependent invasive growth with the mutant exhibiting preferential growth on glucose but severely impaired growth on alternate carbon sources. This pathway in other fungi has been implicated in the regulation of morphogenesis, stress responses, and virulence, but this study is the first one to characterize it in the pathogenic filamentous fungus. In yeast, the RAM network includes the CotA ortholog, Cbk1, and associated proteins, …
Analyzing Fungal Growth Dynamics Under Different Environmental Conditions Using A Lotka–Volterra Competition System, Maria Ordonez, Fabrio Araujo
Analyzing Fungal Growth Dynamics Under Different Environmental Conditions Using A Lotka–Volterra Competition System, Maria Ordonez, Fabrio Araujo
Discovery Day - Daytona Beach
Fungi play a critical role in ecosystems as decomposers that recycle nutrients and maintain environmental balance. Their populations are influenced by multiple environmental factors such as temperature, humidity, nutrient availability, and interactions with other organisms. In this project, the Lotka–Volterra model is used to analyze how competing fungal species interact and how these interactions influence population dynamics over time. By modeling two fungal populations competing for the same limited resources, the equations illustrate how environmental conditions and competition coefficients determine whether one species dominates; both species coexist, or one species becomes extinct. The model provides insight into how changes in …
Validation Of A Real-Time Pcr Laboratory Developed Test For The Detection Of Pneumocystis Jirovecii In Bronchoalveolar Lavage Samples, Caitlyn Moon
Honors Scholar Theses
Pneumocystis jirovecii is an opportunistic, host-obligate fungal pathogen responsible for causing P. jirovecii pneumonia (PJP) in humans. PJP is treated with trimethoprim-sulfamethoxazole (TMP-SMX), a strong broad-spectrum antibiotic that carries risk of renal and hepatotoxicity. Therefore, rapid diagnosis or exclusion of PJP is crucial to ensure PJP-positive patients receive effective treatment and PJP-negative patients avoid unnecessary antibiotics. Unlike most microorganisms, P. jirovecii cannot be cultured, presenting complications for the typical methods of diagnosing fungal pathogens. Historically, the gold standard for diagnosis was direct microscopic examination with stains such as methenamine silver and calcofluor white, but this diagnostic technique requires highly skilled …
Dupilumab For Patients With Allergic Fungal Rhinosinusitis, Amber U. Luong, Joshua M. Levy, Sarah K. Wise, Joseph K. Han, Mamoru Yoshikawa, Luo Zhang, Rodney Schlosser, Prerna Ranganathan, Paula Dakin, Jennifer Maloney, George D. Yancopoulos, Andrew P. Fontenot, Neelam A. Phadke, Lacey R. Robinson
Dupilumab For Patients With Allergic Fungal Rhinosinusitis, Amber U. Luong, Joshua M. Levy, Sarah K. Wise, Joseph K. Han, Mamoru Yoshikawa, Luo Zhang, Rodney Schlosser, Prerna Ranganathan, Paula Dakin, Jennifer Maloney, George D. Yancopoulos, Andrew P. Fontenot, Neelam A. Phadke, Lacey R. Robinson
Department of Otolaryngology (ENT) Faculty Publications
Background
Allergic fungal rhinosinusitis (AFRS) is a severe subtype of chronic rhinosinusitis characterized by fungal hypersensitivity and accentuated type 2 inflammation. Dupilumab-a fully human monoclonal antibody blocking interleukin-4/13, approved for type 2 inflammatory diseases, including chronic rhinosinusitis with nasal polyps-may benefit patients with AFRS.
Objective
We sought to understand the effect of dupilumab in AFRS
Methods
In this phase 3 trial, patients with AFRS aged ≥6 years were randomized to dupilumab or matched placebo for 52 weeks. The primary end point was Lund-Mackay computed tomography (LMK-CT) score, quantifying sinus opacification, at 52 weeks. Secondary end points were multiplicity-controlled and hierarchically …